SFX by Ex Libris Inc.

Title:	A whole-genome association study of major determinants for host control of HIV-1
Source:	Science [0036-8075] Fellay, J yr:2007

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Apps, R. "Influence of HLA-C Expression Level on HIV Control." Science 340.6128 (2013): 87-91.
description	2.	Thye, T. "Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2." Nature Genetics 42.9 (2010): 739-41.
description	3.	Johnston, Margaret I. "Current concepts: An HIV vaccine - Evolving concepts." The New England journal of medicine 356.20 (2007): 2073-2081.
description	4.	Schmitz, J E E. "Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes." Science 283.5403 (1999): 857-60.
description	5.	Fedrigo, O. "Promoter regions of many neural- and nutrition-related genes have experienced positive selection during human evolution." Nature genetics 39.9 (2007): 1140-4.
description	6.	Ottenhoff, Tom H M H. "Ten challenges for TB biomarkers." Tuberculosis 92 Suppl 1.SUPPL.1 (2012): -20.
description	7.	Thye, T. "Common variants at 11p13 are associated with susceptibility to tuberculosis." Nature Genetics 44.3 (2012): 257-259.
description	8.	Sampaio, Lucas H. "Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development." BMC infectious diseases 11 (2011): 26-26.
description	9.	Aagaard, C. "A multistage tuberculosis vaccine that confers efficient protection before and after exposure." Nature medicine 17.2 (2011): 189-194.
description	10.	Daly, Jeffrey J. "Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease." Nature genetics 40.8 (2008): 955-62.
description	11.	Gerdemann, U. "Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections." Molecular therapy 20.8 (2012): 1622-32.
description	12.	Lisziewicz, J. "Nanomedicine Applications Towards the Cure of HIV." Nanomedicine 9.1 (2012): 28-38.
description	13.	Rotger, M. "Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque." The Journal of clinical investigation 121.6 (2011): 2391-2400.
description	14.	Carrington, M. "HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C." Nature Genetics 41.12 (2009): 1290-4.
description	15.	Lama, J. "Host factors influencing susceptibility to HIV infection and AIDS progression." Retrovirology 4.1 (2007): 52-52.
description	16.	Haase, W. "Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells." Science 286.5443 (1999): 1353-7.
description	17.	Letvin, Norman L L. "Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys." Science 312.5779 (2006): 1530-3.
description	18.	Kosslyn, Stephen M M. "Aging and the scope of visual attention." Gerontology international journal of experimental and clinical gerontology 45.2 (1999): 102-109.
description	19.	Ho, V. "HIV/AIDS epidemiology, pathogenesis, prevention, and treatment." Lancet, The 368.9534 (2006): 489-504.
description	20.	Srivastava IK, Indresh K K. "Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design." Expert Review of Vaccines 3.4 Suppl (2004): 33-52.